NCT05440227 2025-06-05
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
PhytoHealth Corporation
Phase 2 Recruiting
Clinical Trials
11 trialsNCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT05212701 2024-04-30
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer
Dompé Farmaceutici S.p.A
Phase 2 Withdrawn
NCT05664009 2024-04-05
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
Canada Royal Enoch Phytomedicine Co., Ltd.
Phase 2 Recruiting
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT02434367 2017-12-14
WWE
The West Clinic, Memphis
Phase 2 Completed
NCT00825227 2017-11-17
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Terminated
NCT02645175 2016-10-21
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Meriyana Bio Inc.
Phase 2 Terminated
NCT01206335 2012-11-27
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
Ohr Pharmaceutical Inc.
Phase 2 Unknown
NCT00047476 2005-06-24
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
Celgene
Phase 2 Completed